397 related articles for article (PubMed ID: 26859610)
1. Evaluating the Psychometric Properties and Responsiveness to Change of 3 Depression Measures in a Sample of Persons With Traumatic Spinal Cord Injury and Major Depressive Disorder.
Williams RT; Heinemann AW; Neumann HD; Fann JR; Forchheimer M; Richardson EJ; Bombardier CH;
Arch Phys Med Rehabil; 2016 Jun; 97(6):929-37. PubMed ID: 26859610
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.
Fann JR; Bombardier CH; Richards JS; Wilson CS; Heinemann AW; Warren AM; Brooks L; McCullumsmith CB; Temkin NR; Warms C; Tate DG;
JAMA Psychiatry; 2015 Mar; 72(3):247-58. PubMed ID: 25607727
[TBL] [Abstract][Full Text] [Related]
3. Differences in quality of life outcomes among depressed spinal cord injury trial participants.
Tate DG; Forchheimer M; Bombardier CH; Heinemann AW; Neumann HD; Fann JR
Arch Phys Med Rehabil; 2015 Feb; 96(2):340-8. PubMed ID: 25450124
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the relationship of spiritual well-being to depression and quality of life for persons with spinal cord injury.
Wilson CS; Forchheimer M; Heinemann AW; Warren AM; McCullumsmith C
Disabil Rehabil; 2017 Mar; 39(5):491-496. PubMed ID: 27109856
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial.
Richards JS; Bombardier CH; Wilson CS; Chiodo AE; Brooks L; Tate DG; Temkin NR; Barber JK; Heinemann AW; McCullumsmith C; Fann JR
Arch Phys Med Rehabil; 2015 Apr; 96(4):680-9. PubMed ID: 25527253
[TBL] [Abstract][Full Text] [Related]
6. Validity of the Patient Health Questionnaire-9 in assessing major depressive disorder during inpatient spinal cord injury rehabilitation.
Bombardier CH; Kalpakjian CZ; Graves DE; Dyer JR; Tate DG; Fann JR
Arch Phys Med Rehabil; 2012 Oct; 93(10):1838-45. PubMed ID: 22555007
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.
Bombardier CH; Fann JR; Wilson CS; Heinemann AW; Richards JS; Warren AM; Brooks L; Warms CA; Temkin NR; Tate DG
J Spinal Cord Med; 2014 May; 37(3):247-63. PubMed ID: 24090228
[TBL] [Abstract][Full Text] [Related]
8. Symptoms of major depression in people with spinal cord injury: implications for screening.
Bombardier CH; Richards JS; Krause JS; Tulsky D; Tate DG
Arch Phys Med Rehabil; 2004 Nov; 85(11):1749-56. PubMed ID: 15520969
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan.
Higuchi T; Kamijima K; Nakagome K; Itamura R; Asami Y; Kuribayashi K; Imaeda T
Int Clin Psychopharmacol; 2016 Jan; 31(1):8-19. PubMed ID: 26513202
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Psychometric Properties of 3 Depression Measures in a Sample of Persons With Traumatic Brain Injury and Major Depressive Disorder.
Dyer JR; Williams R; Bombardier CH; Vannoy S; Fann JR
J Head Trauma Rehabil; 2016; 31(3):225-32. PubMed ID: 26291629
[TBL] [Abstract][Full Text] [Related]
11. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
Perugi G; Frare F; Toni C; Ruffolo G; Torti C
Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
[TBL] [Abstract][Full Text] [Related]
12. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.
Thase M; Asami Y; Wajsbrot D; Dorries K; Boucher M; Pappadopulos E
Curr Med Res Opin; 2017 Feb; 33(2):317-326. PubMed ID: 27794623
[TBL] [Abstract][Full Text] [Related]
14. Identifying depression severity risk factors in persons with traumatic spinal cord injury.
Williams RT; Wilson CS; Heinemann AW; Lazowski LE; Fann JR; Bombardier CH;
Rehabil Psychol; 2014 Feb; 59(1):50-6. PubMed ID: 24611924
[TBL] [Abstract][Full Text] [Related]
15. Major depressive disorder and factorial dimensions among individuals with recent-onset spinal cord injury.
Williamson ML; Elliott TR
Rehabil Psychol; 2013 Feb; 58(1):10-7. PubMed ID: 23437996
[TBL] [Abstract][Full Text] [Related]
16. The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia.
Williams JW; Stellato CP; Cornell J; Barrett JE
Int J Psychiatry Med; 2004; 34(1):37-50. PubMed ID: 15242140
[TBL] [Abstract][Full Text] [Related]
17. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
19. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Utrecht Scale for Evaluation of Rehabilitation-Participation with the ICF Measure of Participation and Activities Screener and the WHO Disability Assessment Schedule II in persons with spinal cord injury.
van der Zee CH; Post MW; Brinkhof MW; Wagenaar RC
Arch Phys Med Rehabil; 2014 Jan; 95(1):87-93. PubMed ID: 24008052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
